CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES (EIN 363918407) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1992

Legal Domicile

Principal Officer

CAROL KRUCHKO

Phone

3238070556

Tax Period

2024-01-01 to 2024-12-31

Central Brain Tumor Registry of the Unit, founded in 1992, is a small nonprofit that reported $250K in total revenue in fiscal year 2019. Expenses of $215K left a modest 14% surplus.

Mission

THE CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES (CBTRUS) IS A NOT- FOR-PROFIT CORPORATION COMMITTED TO PROVIDING A RESOURCE FOR GATHERING AND DISSEMINATING CURRENT EPIDEMIOLOGIC DATA ON ALL PRIMARY BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMORS, MALIGNANT AND NON-MALIGNANT, FOR THE PURPOSES OF ACCURATELY DESCRIBING THEIR INCIDENCE AND SURVIVAL PATTERNS, EVALUATING DIAGNOSIS AND TREATMENT, FACILITATING ETIOLOGIC STUDIES, ESTABLISHING AWARE OF THE DISEASE, AND ULTIMATELY, FOR THE PREVENTION OF ALL BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMORS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $148,364

Program Service Revenue $60,000

Investment Income $52

Other Revenue $0

TOTAL REVENUE $208,416

Expense Breakdown

Grants Paid $0

Salaries & Benefits $75,983

Fundraising Expenses $13,293

Program Expenses $204,239

Other Expenses $158,464

TOTAL EXPENSES $234,447

Year-over-Year Comparison

	2024	2023	Change
Revenue	$208,416	N/A	N/A
Expenses	$234,447	N/A	N/A
Net Income	$-26,031	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$70,583

Total Directors

$70,583

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CAROL KRUCHKO	PRESIDENT &	40.00	Officer Director	$70,583	$0	$70,583
DR DARELL D BIGNER	EMERITUS	N/A	Director	$0	$0	$0
DR STEVEN BREM	VICE PRESIDE	N/A	Director	$0	$0	$0
DR ELIZABETH CLAUS	TRUSTEE	N/A	Director	$0	$0	$0
DR FRED H HOCHBERG	TRUSTEE	N/A	Director	$0	$0	$0
DONALD SEGAL JD	TREASURER	N/A	Director	$0	$0	$0
MARGARET WRENSCH PHD	TRUSTEE	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$208,416	$234,447	$115,415	$-26,031
2021	$241,093	$176,350	$249,048	$64,743
2019	$249,511	$214,501	$278,804	$35,010

CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES